Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome

Citation
T. Tarumi et al., Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome, BLOOD, 96(3), 2000, pp. 1191-1193
Citations number
17
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
96
Issue
3
Year of publication
2000
Pages
1191 - 1193
Database
ISI
SICI code
0006-4971(20000801)96:3<1191:FTAWFP>2.0.ZU;2-5
Abstract
We report on a family with a history of venous thromboembolism associated w ith fibrinogen Paris V (fibrinogen A alpha-Arg554-->Cys), Ten members exper ienced thrombotic events, including 4 with fatal pulmonary emboli, Pulmonar y embolism was the presenting feature in 4, Those with the mutation and a h istory of thrombosis had somewhat higher fibrinogen concentrations than tho se with the mutation and no thrombosis (294 +/- 70 mg/dL vs 217 +/- 37 mg/d L., respectively), The Paris V mutation consistently caused a prolongation of the reptilase time, and fibrin clots containing the abnormal fibrinogen were more translucent than normal clots. Given the early onset of symptoms and the initial presentation with pulmonary embolism in some family members , it was justifiable to offer prophylactic anticoagulation with warfarin to carriers of the mutation. Fibrinogen Paris V has now been reported in 4 ap parently unrelated families, indicating that it is a relatively common caus e of dysfibrinogenemia-associated thrombosis. (C) 2000 by The American Soci ety of Hematology.